SCHEMBL13214142

SCHEMBL13214142

CCCCCc1cc(OC)c2c(c1)OC(C)(C)c1ccc(C)cc1-2

nearest known ligand 0.78

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 15/20 0.78
▸ CNR1 P21554 13/20 0.78
▸ TRPA1 O75762 2/20 0.78
▸ TRPV1 Q8NER1 2/20 0.78
▸ TRPV3 Q8NET8 2/20 0.78
▸ TRPV4 Q9HBA0 2/20 0.78
▸ TRPV2 Q9Y5S1 2/20 0.78
▸ CYP1A1 P04798 1/20 0.78
▸ CYP1A2 P05177 1/20 0.78
▸ CYP2A6 P11509 1/20 0.78
▸ CYP2B6 P20813 1/20 0.78
▸ SLC6A2 P23975 1/20 0.78
▸ HTR2A P28223 1/20 0.78
▸ SLC6A4 P31645 1/20 0.78
▸ OPRM1 P35372 1/20 0.78
▸ CYP2J2 P51589 1/20 0.78
▸ CYP1B1 Q16678 1/20 0.78
▸ PPARG P37231 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29976337 1.00 CNR2 (0.78) CNR2CNR1TRPA1TRPV1TRPV3
SCHEMBL31395509 0.89 CNR2 (0.74) CNR2CNR1TRPA1TRPV1TRPV3
Cannabinol SCHEMBL16061830 0.89 CNR2 (0.93) CNR2CNR1TRPA1TRPV1TRPV3
Cannabinol SCHEMBL23460333 0.87 CNR2 (1.00) CNR2CNR1TRPA1TRPV1TRPV3
Cannabinol SCHEMBL29433714 0.87 CNR2 (1.00) CNR2CNR1TRPA1TRPV1TRPV3
Cannabinol SCHEMBL29815206 0.87 CNR2 (1.00) CNR2CNR1TRPA1TRPV1TRPV3
Cannabinol SCHEMBL121085 0.87 CNR2 (1.00) CNR2CNR1TRPA1TRPV1TRPV3
Cannabinol SCHEMBL29350505 0.87 CNR2 (1.00) CNR2CNR1TRPA1TRPV1TRPV3
SCHEMBL31537221 0.87 CNR2 (0.72) CNR2CNR1TRPA1TRPV1TRPV3
SCHEMBL31537332 0.87 CNR2 (0.72) CNR2CNR1TRPA1TRPV1TRPV3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 209 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250161332-A1 NON-PSYCHOACTIVE MULTI-CANNABINOID AND POLYSACCHARIDE AND POLYSACCHAROPEPTIDE-BASED THERAPEUTIC COMPOSITIONS AND METHODS OF THEIR ADMINISTRATIO PEBBLE GLOBAL HOLDINGS (US) 2025-05-22 — — US claimed
EP-4021415-B1 CANNABINOID CONTAINING TARGETING LIPOSOMES NEXTAGE THERAPEUTICS LTD (IL) 2025-05-14 — — EP claimed
US-20240398839-A1 CANNABINOID-LIPID CONJUGATES, METHODS FOR PRODUCING THE SAME AND USES THEREOF RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2024-12-05 — — US claimed
US-20240285702-A1 Compositions comprising a cannabinoid and uses thereof CANNABOTECH LTD (IL) 2024-08-29 — — US claimed
CN-113966213-B Self-emulsifying drug delivery system for delivery of lipophilic compounds 耶路撒冷希伯来大学伊森姆研究发展有限公司 2024-08-27 — — CN claimed
EP-4405322-A1 CANNABINOID-LIPID CONJUGATES, METHODS FOR PRODUCING THE SAME AND USES THEREOF Ramot at Tel-Aviv University Ltd. (IL) 2024-07-31 — — EP claimed
US-20240189376-A1 NOVEL MUSHROOM STRAINS, EXTRACTS THEREOF AND COMPOSITIONS COMPRISING THEM CANNABOTECH LTD (IL) 2024-06-13 — — US claimed
EP-4346763-A1 COMPOSITIONS COMPRISING A CANNABINOID AND USES THEREOF Cannabotech Ltd. (IL) 2024-04-10 — — EP claimed
EP-4308137-A1 NOVEL MUSHROOM STRAINS, EXTRACTS THEREOF AND COMPOSITIONS COMPRISING THEM Cannabotech Ltd. (IL) 2024-01-24 — — EP claimed
WO-2023047399-A1 CANNABINOID-LIPID CONJUGATES, METHODS FOR PRODUCING THE SAME AND USES THEREOF RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2023-03-30 — — WO claimed
EP-4093393-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATORY CONDITIONS AND DISEASES OF THE SKIN Landver, Guy (IL) 2022-11-30 — — EP claimed
EP-4087592-A1 METHODS FOR OBTAINING COMPOUNDS FROM A PLANT OR FUNGUS MATERIAL, RESPECTIVE COMPOSITIONS, AND USES THEREOF Real Isolates, LLC (US) 2022-11-16 — — EP claimed
EP-4065105-A1 CANNABINOID AND LYCOPENE ANTI-INFLAMMATORY SYNERGISTIC COMBINATIONS Lycored Ltd. (IL) 2022-10-05 — — EP claimed
WO-2022195581-A1 NOVEL MUSHROOM STRAINS, EXTRACTS THEREOF AND COMPOSITIONS COMPRISING THEM CANNABOTECH LTD. (IL) 2022-09-22 — — WO claimed
CN-114980882-A Synergistic combination of cannabinoid and lycopene anti-inflammatory 乐康瑞德有限公司 2022-08-30 — — CN claimed
US-20220265555-A1 CANNABINOID CONTAINING TARGETING LIPOSOMES NEXTAGE THERAPEUTICS LTD. (IL) 2022-08-25 — — US claimed
US-20220218877-A1 CANNABINOID POLYMERIC COMPOSITIONS CANNASSURE LTD (IL) 2022-07-14 — — US claimed
EP-4021415-A1 CANNABINOID CONTAINING TARGETING LIPOSOMES Nextage Therapeutics Ltd. (IL) 2022-07-06 — — EP claimed
WO-2022091080-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF AUTISM SPECTRUM DISORDER SEACH SARID LTD. (IL) 2022-05-05 — — WO claimed
CN-114207108-A Genetically modified host cells producing glycosylated cannabinoids 奥克塔林生物制剂公司 2022-03-18 — — CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240398839-A1 CANNABINOID-LIPID CONJUGATES, METHODS FOR PRODUCING THE SAME AND USES THEREOF PHOSPHO1, CNR2, FAAH CNR2 2/4885CNR1 7/4885TRPA1 2530/4885
US-20220265555-A1 CANNABINOID CONTAINING TARGETING LIPOSOMES CNR2, CNR1, MAG CNR2 1/4885CNR1 2/4885TRPA1 3000/4885
US-20220218877-A1 CANNABINOID POLYMERIC COMPOSITIONS CNR2, CNR1, BRCA1 CNR2 1/4885CNR1 2/4885TRPA1 327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback